Aurora Spine Corporation (ASAPF) Stock

About Aurora Spine Corporation

Aurora Spine Corporation, operating through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. The company's diverse product portfolio includes a range of interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 lines, specifically engineered to treat patients suffering from degenerative disc diseases. Additionally, Aurora Spine provides titanium-coated polyether ether ketone (PEEK) interbody cages. These cages are crucial for maintaining proper spacing and stability between spinal vertebrae, thereby encouraging bone growth to achieve successful fusion. Aurora Spine also supplies sterile, titanium plasma spray coated spinal implants designed to promote bone integration. Complementing these, it offers a suite of interbody products such as the EOS, VOX, Echo, Echo SD, and EchoXL series for lumbar applications, and the Discovery system for cervical surgeries. Among its innovations is SOLO, a 3D-printed, stand-alone anterior lumbar interbody fusion device. This integrated plate and spacer system is designed to maintain the spine's natural anatomical alignment while delivering essential support and stability to the spinal column. Another key offering is SiLo, a posterior fusion device specifically developed for the sacroiliac joint. Furthermore, the DEXA-C cervical interbody system stands out as a porous, 3D-printed intervertebral body fusion device. It features customizable low-, mid-, or high-density lattice patterns, allowing for precise matching with individual patient bone quality. Established in 2013, Aurora Spine Corporation has its corporate headquarters situated in Toronto, Canada.

Aurora Spine Corporation is headquartered in CA.

Aurora Spine Corporation (ASAPF) stock trades at $0.14 with a market capitalization of $11.21M. The stock is valued at a price-to-earnings (P/E) ratio of -19.73, price-to-book of 3.23, price-to-sales of 0.64. Over the past 52 weeks the stock has ranged between $0.14 and $0.25, and currently trades 44.0% below its 52-week high.

On profitability, Aurora Spine Corporation generates a return on equity (ROE) of -15.61%, return on capital employed of -3.19%, an operating margin of -1.19%, a net profit margin of -3.24%.

Official website: www.aurora-spine.com